Source:http://linkedlifedata.com/resource/pubmed/id/13420949
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
19
|
pubmed:dateCreated |
1957-12-1
|
pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/DIABETES MELLITUS/therapy,
http://linkedlifedata.com/resource/pubmed/keyword/SULFANILAMIDE/related compounds,
http://linkedlifedata.com/resource/pubmed/keyword/SULFONAMIDES/therapeutic use,
http://linkedlifedata.com/resource/pubmed/keyword/UREA/related compounds
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
OM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0034-9615
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
15-23
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading | |
pubmed:articleTitle |
[Special clinical questions in the treatment of diabetes with sulfonylcarbamide derivatives].
|
pubmed:publicationType |
Journal Article
|